Understanding the crosstalk between cytoskeletal mechanics and inflammatory signalling may reveal novel regulatory mechanisms and identify promising therapeutic targets for rheumatoid arthritis.
Rheumatoid arthritis (RA) is a chronic systemic autoimmune disease characterized by persistent synovitis, pannus formation, cartilage degradation, and bone erosion. Although conventional synthetic, biologic, and targeted synthetic disease-modifying antirheumatic drugs have improved disease control, many patients fail t...
Lun-Min Bao, Hai-Bing Dai, Dao-Ming Wang et al.· Frontiers in Pharmacology· 0 citations
Osteoarthritis (OA) is a whole-joint disease involving cartilage, synovium, subchondral bone, and neurovascular structures. Synovitis, damage-associated molecular patterns, and interactions between macrophages and fibroblast-like synoviocytes have been widely studied. However, a tissue-level explanation is still lackin...
Kang-Yi Hu, Yong-Jia Song, Jia-Xing Pan et al.· Frontiers in Immunology· 0 citations
Rheumatoid arthritis (RA) is a chronic autoimmune disease that causes long-term destruction of cartilage and leads to irreversible arthritis. Pro-inflammatory messengers such as interleukin-1 beta (IL-1 beta), tumour necrosis factor-alpha (TNF alpha), interleukin-6 (IL-6), and interleukin-17 (IL-17)—drive this destruct...
Subhendu Dey, Chayanika Goswami, Tanmay Mohanta et al.· Genetics and Molecular Resea...· 0 citations
The data suggests that the high levels of CD248 expression seen on synovial fibroblasts provides a protective brake that attenuates bone damage by preventing the polarisation of emergent fibroblasts towards a destructive phenotype.
Samuel Kemble, C. Wehmeyer, James M. Brown et al.· Arthritis & Rheumatology· 0 citations
Osteoarthritis (OA) has conventionally been considered a degenerative mechanical condition; but an increasing number of studies support an alternative perception of this disease as one characterized by impaired immune homeostasis in the joint environment. The purpose of this review is to analyze the mechanisms of how t...
Approximately 5% to 20% of patients with rheumatoid arthritis (RA) fail to respond to sequential biologic and targeted synthetic disease-modifying antirheumatic drugs, representing a major unmet clinical need. Increasing evidence indicates that a substantial proportion of these patients exhibit a pauci-immune (fibroid)...
M. Elhai· EULAR rheumatology open· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.